Table 2. GSEA analysis of published gene sets.

PATHWAY/GENE SET	SIZEa	ESb	NESc	p-val	FDR	CSd	REFe
LS vs NL:
PSORIASIS_SF_UP	551	0.88	3.89	0.000	0.000	0.86	[20]
PSORIASIS_SF_DOWN	680	−0.83	−4.29	0.000	0.000
Relapse vs Week 12:
PSORIASIS_SF_UP	569	0.85	4.26	0.000	0.000	0.84	[20]
PSORIASIS_SF_DOWN	694	−0.82	−4.25	0.000	0.000
IL22 KC_UP	11	0.86	2.16	0.000	0.000	0.84	[21]
IL22 KC_DOWN	10	−0.82	−2.05	0.000	0.000
IFNG KC_UP	907	0.42	2.19	0.000	0.000	0.34	[21]
IFNG KC_DOWN	332	−0.25	−1.23	0.050	0.128
IL17&TNF KC UP	31	0.87	2.82	0.000	0.000		[22]
IL1 KC_UP	48	0.75	2.68	0.000	0.000		[23]
TERMINAL DIFFERENTIATION	33	0.58	1.86	0.000	0.001		[24]
PS_INFLAMM DCS_UP	131	0.33	1.41	0.008	0.041		[18]

^aSize, number of genes in gene set.

^bES, enrichment score.

^cNES, normalized enrichment score.

^dCS, connectivity score.

^eREF, reference for gene set.